These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12756111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
    Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R.
    J Rheumatol; 1992 Oct; 19(10):1537-41. PubMed ID: 1334515
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
    Chen X, Wang S, Wu N, Sood S, Wang P, Jin Z, Beer DG, Giordano TJ, Lin Y, Shih WC, Lubet RA, Yang CS.
    Clin Cancer Res; 2004 Oct 01; 10(19):6703-9. PubMed ID: 15475461
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.
    DuBuske LM, Grossman J, Dubé LM, Swanson LJ, Lancaster JF.
    Am J Manag Care; 1997 Apr 01; 3(4):633-40. PubMed ID: 10169531
    [Abstract] [Full Text] [Related]

  • 8. Zileuton.
    McGill KA, Busse WW.
    Lancet; 1996 Aug 24; 348(9026):519-24. PubMed ID: 8757156
    [No Abstract] [Full Text] [Related]

  • 9. Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
    Woodruff PG, Albert RK, Bailey WC, Casaburi R, Connett JE, Cooper JA, Criner GJ, Curtis JL, Dransfield MT, Han MK, Harnden SM, Kim V, Marchetti N, Martinez FJ, McEvoy CE, Niewoehner DE, Reilly JJ, Rice K, Scanlon PD, Scharf SM, Sciurba FC, Washko GR, Lazarus SC, Copd Clinical Research Network.
    COPD; 2011 Feb 24; 8(1):21-9. PubMed ID: 21299475
    [Abstract] [Full Text] [Related]

  • 10. The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: a 6-month randomized controlled study.
    Wenzel S, Busse W, Calhoun W, Panettieri R, Peters-Golden M, Dube L, Walton-Bowen K, Russell H, Harris J.
    J Asthma; 2007 May 24; 44(4):305-10. PubMed ID: 17530530
    [Abstract] [Full Text] [Related]

  • 11. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK, Richer LD, Elstad MR.
    Chest; 2005 Feb 24; 127(2):565-70. PubMed ID: 15705997
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway.
    Drazen JM, Israel E.
    Int Arch Allergy Immunol; 1995 Feb 24; 107(1-3):319-20. PubMed ID: 7613158
    [Abstract] [Full Text] [Related]

  • 16. The effect of zileuton on antipyrine and indocyanine green disposition.
    St Peter JV, Braeckman RA, Granneman GR, Locke CS, Cavanaugh JH, Awni WM.
    Clin Pharmacol Ther; 1995 Mar 24; 57(3):299-308. PubMed ID: 7697947
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus.
    Hackshaw KV, Shi Y, Brandwein SR, Jones K, Westcott JY.
    J Rheumatol; 1995 Mar 24; 22(3):462-8. PubMed ID: 7783062
    [Abstract] [Full Text] [Related]

  • 18. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE.
    Am J Respir Crit Care Med; 1998 Apr 24; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.
    Meltzer SS, Hasday JD, Cohn J, Bleecker ER.
    Am J Respir Crit Care Med; 1996 Mar 24; 153(3):931-5. PubMed ID: 8630575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.